A multi-institution research team led by the University of Illinois — with sustained funding from the North Central Soybean ...
SALT LAKE CITY, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced its support for a recent guideline update ...
Revvity's Dharmacon All-in-one lentiviral platform has expanded to include whole-genome library options for CRISPR knockout (CRISPRko), CRISPR interference (CRISPRi), and CRISPR activation (CRISPRa).
Genetic testing can play an important role in identifying patients at risk for malignant hyperthermia (MH), guided by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results